| Tamika Nicole Braddy, | |
|
1000 Clyburn Pl, Aiken, SC 29801-4193 | |
| (803) 380-7000 | |
| (803) 642-6186 |
| Full Name | Tamika Nicole Braddy |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1000 Clyburn Pl, Aiken, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376320960 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LPN095920 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tamika Nicole Braddy, 1000 Clyburn Pl, Aiken, SC 29801-4193 Ph: () - | Tamika Nicole Braddy, 1000 Clyburn Pl, Aiken, SC 29801-4193 Ph: (803) 380-7000 |
News Archive
Low-income housing residents who live in "green" buildings that are built with eco-friendly materials and energy-efficient features appear to have fewer "sick building" symptoms (SBS) than residents of traditionally constructed low-income housing, according to a new study led by researchers at Harvard T.H. Chan School of Public Health.
Bethesda, MD-Japanese researchers have made a new step toward understanding why-and how to stop-runaway inflammation for both chronic obstructive pulmonary disorder (COPD) and allergic asthma. In a new report appearing in the August 2013 issue of The FASEB Journal scientists show that two receptors of an inflammatory molecule, called "leukotriene B4," play opposing roles in turning inflammation on and off for allergic asthma and COPD.
Over the past six months, the World Health Organization has categorized four SARS-CoV-2 variants as being "of concern" because they are more transmissible or may escape the immune response.
One year after graduating from the Cedars-Sinai Accelerator powered by Techstars, several health-tech startups are swiftly expanding their innovations into hospitals and other healthcare settings for the benefit of patients.
Patients with HER2-positive cancers can have dramatic responses to HER2-targeted drugs but eventually develop resistance to the agents. With that problem in mind, Fox Chase Cancer Center researchers are testing a novel type of antibody called MM-111 in patients with HER2-positive disease who have progressed on standard therapy.
› Verified 3 days ago
Tijuana Davis Carolina, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1000 Clyburn Pl, Aiken, SC 29801 Phone: 803-380-7000 Fax: 803-648-2584 | |
Isabelle Messer, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 785 University Pkwy Apt A3, Aiken, SC 29801 Phone: 803-644-4366 Fax: 803-644-5062 |